Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

More documents

Recommendations

Info

268 BRITISH COLUMBIA APPENDIX 9. Healthcare Research Centres (cont’d) RESEARCH CENTRE/ URL CONTACT DESCRIPTION Immunity & Infection Research Centre (IIRC) VCHRI www.iirc.ca/Immunity_and_Infection_Research_Centre.htm Prevention of Organ Failure Centre of Excellence (PROOF) www.proof.hli.ubc.ca IIRC labs are at: • Heather Pavilion East, 2733 Heather Street V5Z 3J5 • Jack Bell Research Centre, 2660 Oak Street B.C. V6H 3Z6 • Research Pavilion, 828 West 10th Avenue V6Z 1L8 • B.C. Centre for Disease Control, 655 West 12th Avenue V5Z 4R4 Contact: Jeffrey Helm, Research Co-ordinator 604-875-4111 x 68576 jhelm@interchange.ubc.ca Room 166, Burrard Building, 1081 Burrard Street, Vancouver B.C. V6Z 1Y6 Tel: 604-806-8328 Fax: 604-806-9274 proof@hli.ubc.ca Contact: Marjorie Co, Chief Development Officer Tel: 604-806-8934 Marjorie.Co@hli.ubc.ca 8. OTHER DISEASE-BASED HEALTH RESEARCH CENTRES B.C. Provincial Renal Agency (BCPRA) www.bcrenalagency. ca/default.htm B.C. Provincial Renal Agency St Paul’s Hospital 700-1380 Burrard Street Vancouver B.C. V6Z 2H3 Tel: 604-875-7340 Contact: Adeera Levin bcpra@bcpra.ca A collaborative team of basic scientists, clinicians, and health professionals whose expertise spans genomics, molecular microbiology, immunology, infectious diseases, transplantation immunology, medical genetics, epidemiology, health care delivery, and policy development. IIRC research interests include basic mechanisms of human immune responses involved in transplantation and infectious diseases in order to improve public health outcomes and health services. Current programs Include: • Transplant immunology • PREPARE - proteomics approaches to rapidly identify novel targets in microbial pathogens leading to novel therapeutics and vaccines for emerging infectious diseases. • Centre for Human Islet Transplant and Beta Cell Regeneration: transplantation of beta-cells is a promising treatment option that eliminates the need for insulin injections. CHITBCR conducts research to address the main limitations of beta-cell transplant. The PROOF Centre discovers, develops, commercializes and implements non-invasive tests (biomarkers) for prevention, diagnosis, prediction, management, and treatment of diseases associated with organ failure. It carries forward programs in the development of biomarkers for heart, lung, and kidney failure as well as for new blood assays for genes, proteins, and metabolites. One of the PROOF Centre’s flagship programs is the “Biomarkers in Transplantation” initiative. Now in its second phase, this innovative project has identified biomarkers in the blood that will tell the clinical transplant team immediately whether a transplanted organ is being rejected, using a simple blood test. BCPRA plans and monitors the delivery of province-wide kidney care services. BCPRA addresses the challenge of kidney disease by: • improving early diagnosis and treatment • ensuring that the system itself is financially sustainable • educating British Columbians about the risks and signs of kidney disease BCPRA activities include: • Plans and monitors the delivery of province-wide kidney care services • Develops province-wide clinical standards and guidelines • Develops funding models to support best health outcomes • Measures and reports on patient and system outcomes • Supports knowledge-development through research and teaching.
CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP 269 RESEARCH CENTRE/ URL CONTACT DESCRIPTION Centre for Hip Health & Mobility (CHHM), VCHRI www.hiphealth.ca The Department of Dermatology and Skin Science (DDSC) http://www.derm.ubc. ca/about_ubc_dermatology/default.htm 3/F 2647 Willow Street Willow Chest Centre Vancouver, B.C. V5Z 1M9 Tel: 604-875-5250 Fax: 604-875-4762 chhcontactus@hiphealth.ca DDSC 835 West 10th Avenue Vancouver, B.C. V5Z 4E8 Tel: 604-875-4747 Fax: 604-873-9919 Department Head: Harvey Lui Research Directors: Jan Dutz, Gang Li Contact: Karen Ng, Administrator Tel: 604-875-4111 x 61324 karen.ng@ubc.ca 9. CHILD AND YOUTH HEALTH RESEARCH CENTRES Child and Family Health Research Institute (CFRI) www.cfri.ca 950 West 28th Avenue Vancouver, B.C. V5Z 4H4 Tel: 604-875-3194 Fax: 604-875-3076 MacLeod, Stuart: Executive Director Tel: 604-875-2404 smacleod@cw.bc.ca CHHM aims to prevent falls and hip fractures through early intervention with programs for youths and seniors, educate and train skilled scientists and clinicians, detect osteoarthritis at an early stage, treat bone and joint problems with more effective surgical solutions, including minimally invasive surgeries, evaluate the impact, effectiveness and costs of novel interventions, translate research that is relevant, effective and sustainable into programs, practices and policies through knowledge integration. CHHM brings together researchers from a wide range of disciplines to investigate and treat hip fractures and osteoarthritis, and create new surgical solutions CHHM integrated research program focuses on four key areas: • Hip Fracture Prevention. • Early Detection of Hip Osteoarthritis • Surgical Solutions • Knowledge Translation DDSC trains undergraduate medical students to have a grounding and basic training in Dermatology through the Undergraduate Program, while graduate medical students are trained to become fully licensed Dermatologists in our Postgraduate Program for residents. DDSC Research involves research through the Clinical Trials Unit and our five specialized laboratories: • Skin Cancer Biology Laboratory • Photomedicine and Optics Laboratory • Hair Research Laboratory • Immunodermatology Laboratory • Laboratory of Predictive Medicine and Therapeutics By analyzing the needs of the community, DDSC design research projects to address those needs. The output of DDSC research is new knowledge, new drugs, new techniques, new patents, and more – DDSC take this information back to our clinical settings to help and treat out patients. CFHRI is the largest child and family-related research institute in Western Canada and works in close partnership with B.C. Children’s Hospital and Sunny Hill Health Centre for Children, B.C. Women’s Hospital & Health Centre, agencies of the Provincial Health Services Authority; B.C. Children’s Hospital Foundation; and UBC. Research spans a wide range of children’s and women’s health concerns. Main areas of research are: • Childhood Cancer • Diabetes, Nutrition & Metabolism • Developmental Neurosciences & Child Health • Genetics & Health • Immunity in Health & Disease • Innovations in Acute Care & Technology • Reproduction & Healthy Pregnancy.
Page 1:
M A G N E T I C 12 0 40 33 0 34 0 3
Page 4 and 5:
ii BRITISH COLUMBIA
Page 6 and 7:
2 BRITISH COLUMBIA EXECUTIVE SUMMAR
Page 8 and 9:
4 BRITISH COLUMBIA INTRODUCTION Wit
Page 10 and 11:
6 BRITISH COLUMBIA TABLE 1. Health
Page 12 and 13:
8 BRITISH COLUMBIA FIGURE 2. Clinic
Page 14 and 15:
10 BRITISH COLUMBIA TABLE 2. Clinic
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
22 BRITISH COLUMBIA Much clinical r
Page 28 and 29:
24 BRITISH COLUMBIA FIGURE 3. Sourc
Page 30 and 31:
26 BRITISH COLUMBIA FIGURE 7. Thera
Page 32 and 33:
28 BRITISH COLUMBIA Clinical Invest
Page 34 and 35:
30 BRITISH COLUMBIA TABLE 6. Patien
Page 36 and 37:
32 BRITISH COLUMBIA FIGURE 13. Prov
Page 38 and 39:
34 BRITISH COLUMBIA TABLE 9. Health
Page 40 and 41:
36 BRITISH COLUMBIA TABLE 10. Epide
Page 42 and 43:
38 BRITISH COLUMBIA TABLE 12. Provi
Page 44 and 45:
40 BRITISH COLUMBIA TABLE 13. Examp
Page 46 and 47:
42 BRITISH COLUMBIA TABLE 13. Examp
Page 48 and 49:
44 BRITISH COLUMBIA TABLE 14. Indep
Page 50 and 51:
46 BRITISH COLUMBIA COMPARATIVE POS
Page 52 and 53:
48 BRITISH COLUMBIA ACKNOWLEDGEMENT
Page 54 and 55:
50 BRITISH COLUMBIA APPENDIX 1-2 TA
Page 56 and 57:
52 BRITISH COLUMBIA APPENDIX 1. DES
Page 58 and 59:
54 BRITISH COLUMBIA Edward Miller C
Page 60 and 61:
56 BRITISH COLUMBIA Radiation Thera
Page 62 and 63:
58 BRITISH COLUMBIA The Unit has 15
Page 64 and 65:
60 BRITISH COLUMBIA Neonatal Resear
Page 66 and 67:
62 BRITISH COLUMBIA The B.C. Childr
Page 68 and 69:
64 BRITISH COLUMBIA The clinical tr
Page 70 and 71:
66 BRITISH COLUMBIA FRASER HEALTH A
Page 72 and 73:
68 BRITISH COLUMBIA tional therapis
Page 74 and 75:
70 BRITISH COLUMBIA PROVIDENCE HEAL
Page 76 and 77:
72 BRITISH COLUMBIA Quality control
Page 78 and 79:
74 BRITISH COLUMBIA Clinical trials
Page 80 and 81:
76 BRITISH COLUMBIA The facility ha
Page 82 and 83:
78 BRITISH COLUMBIA Staffing of the
Page 84 and 85:
80 BRITISH COLUMBIA Investigators:
Page 86 and 87:
82 BRITISH COLUMBIA Quality control
Page 88 and 89:
84 BRITISH COLUMBIA The Research Gr
Page 90 and 91:
86 BRITISH COLUMBIA Multiple Sclero
Page 92 and 93:
88 BRITISH COLUMBIA Gastroenterolog
Page 94 and 95:
90 BRITISH COLUMBIA Since the Centr
Page 96 and 97:
92 BRITISH COLUMBIA TABLE A1. Provi
Page 98 and 99:
94 BRITISH COLUMBIA FIGURE A9. Cent
Page 100 and 101:
96 BRITISH COLUMBIA The Unit suppor
Page 102 and 103:
98 BRITISH COLUMBIA TABLE A2. CFRI
Page 104 and 105:
100 BRITISH COLUMBIA Quality contro
Page 106 and 107:
102 BRITISH COLUMBIA • Knowledge
Page 108 and 109:
104 BRITISH COLUMBIA Its staffing i
Page 110 and 111:
106 BRITISH COLUMBIA APPENDIX 3. QU
Page 112 and 113:
108 BRITISH COLUMBIA APPENDIX 5. CL
Page 114 and 115:
110 BRITISH COLUMBIA APPENDIX 5. Cl
Page 116 and 117:
112 BRITISH COLUMBIA APPENDIX 6 TAB
Page 118 and 119:
114 BRITISH COLUMBIA 6.1 Clinical T
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223: 218 BRITISH COLUMBIA 6.2 Clinical T
Page 242 and 243: 238 BRITISH COLUMBIA Pediatrics INV
Page 244 and 245: 240 BRITISH COLUMBIA Pediatrics (co
Page 252 and 253: 248 BRITISH COLUMBIA APPENDICES 7-1
Page 254 and 255: 250 BRITISH COLUMBIA TABLE A3. Pati
Page 256 and 257: 252 BRITISH COLUMBIA TABLE A3. Pati
Page 258 and 259: 254 BRITISH COLUMBIA APPENDIX 8. PR
Page 260 and 261: 256 BRITISH COLUMBIA APPENDIX 8. Pr
Page 262 and 263: 258 BRITISH COLUMBIA APPENDIX 9. He
Page 288 and 289: 284 BRITISH COLUMBIA APPENDIX 10. N
Page 290 and 291: 286 BRITISH COLUMBIA Networks In Wh
Page 296 and 297: 292 BRITISH COLUMBIA APPENDIX 11. I
Page 310 and 311: 306 BRITISH COLUMBIA APPENDIX 12. P
Page 316 and 317: 312 BRITISH COLUMBIA B.C. Centre fo
Page 318 and 319: 314 BRITISH COLUMBIA University of
Page 320: 316 BRITISH COLUMBIA
show all

Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?